| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30053474 | HIV | ENSG00000125966.10 | protein_coding | MMP24 | No | No | 10893 | Q86VV6 Q9Y5R2 |
| TVIS20036866 | HPV | ENSG00000125966.10 | protein_coding | MMP24 | No | No | 10893 | Q86VV6 Q9Y5R2 |
| TVIS44013657 | HTLV-1 | ENSG00000125966.10 | protein_coding | MMP24 | No | No | 10893 | Q86VV6 Q9Y5R2 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | MMP24 |
|---|---|
| DrugBank ID | DB00786 |
| Drug Name | Marimastat |
| Target ID | BE0003699 |
| UniProt ID | Q9Y5R2 |
| Regulation Type | inhibitor |
| PubMed IDs | 10852638; 10669951 |
| Citations | Heath EI, Grochow LB: Clinical potential of matrix metalloprotease inhibitors in cancer therapy. Drugs. 2000 May;59(5):1043-55.@@Belotti D, Paganoni P, Giavazzi R: MMP inhibitors: experimental and clinical studies. Int J Biol Markers. 1999 Oct-Dec;14(4):232-8. |
| Groups | Investigational |
| Direct Classification | Secondary alcohols |
| SMILES | CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C |
| Pathways | |
| PharmGKB | PA164748329 |
| ChEMBL | CHEMBL279785 |
